Free Trial

Chemomab Therapeutics (CMMB) Institutional Ownership

Chemomab Therapeutics logo
$1.77 +0.03 (+1.72%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$1.77 0.00 (0.00%)
As of 05/8/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)

Current
Institutional Ownership
Percentage
46.05%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$335.71K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$3.79M
Get CMMB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CMMB Institutional Buying and Selling by Quarter

Chemomab Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/20/2026 Kestra Private Wealth Services LLC61,710$97K0.0%+19.3%0.858%
2/18/2026XTX Topco Ltd19,013$31K0.0%N/A0.309%
2/17/2026ADAR1 Capital Management LLC80,000$132K0.0%N/A1.299%
1/29/2026 Kestra Private Wealth Services LLC51,710$85K0.0%N/A0.839%
11/6/2025Rhumbline Advisers9,505$25K0.0%-76.2%0.184%
8/14/2025Orbimed Advisors LLC940,990$1.09M0.0%-46.0%4.990%
5/12/2025Virtu Financial LLC30,803$34K0.0%+113.2%0.215%
4/28/2025Yelin Lapidot Holdings Management Ltd.578,291$630K0.1%-22.3%4.027%
2/13/2025XTX Topco Ltd24,929$45K0.0%+63.8%0.174%
2/11/2025Virtu Financial LLC14,445$26K0.0%N/A0.101%
2/5/2025Yelin Lapidot Holdings Management Ltd.744,127$1.35M0.2%-8.1%5.182%
11/15/2024Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458%
2/1/2023Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271%
2/14/2022GSA Capital Partners LLP11,277$78K0.0%N/A0.099%


CMMB Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Sphera Funds Management LTD. ($1.91M), Orbimed Advisors LLC ($1.09M), Yelin Lapidot Holdings Management Ltd. ($630K), ADAR1 Capital Management LLC ($132K), Kestra Private Wealth Services LLC ($97K), Virtu Financial LLC ($34K), and XTX Topco Ltd ($31K).Learn more on Chemomab Therapeutics' institutional investors.

46.05% of Chemomab Therapeutics' stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings.

The following institutional investors have purchased Chemomab Therapeutics' stock in the last 24 months: Sphera Funds Management LTD. ($1.21M), ADAR1 Capital Management LLC ($80K), Kestra Private Wealth Services LLC ($61.71K), Virtu Financial LLC ($30.80K), and XTX Topco Ltd ($28.72K).

Institutional investors have bought a total of 177,081 shares in the last 24 months. This purchase volume represents approximately $335.71K in transactions.

The following institutional investors have sold Chemomab Therapeutics stock in the last 24 months: Orbimed Advisors LLC ($800.28K), and Rhumbline Advisers ($30.37K).

Institutional investors have sold a total of 830,653 shares in the last 24 months. This volume of shares sold represents approximately $3.79M in transactions.



This page (NASDAQ:CMMB) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners